Pilgrim Foods Division of Old Dutch Mustard Co., Inc. in Greenville, New Hampshire receives FDA inspection

Pilgrim Foods Division of Old Dutch Mustard Co., Inc. in Greenville, New Hampshire receives FDA inspection
0Comments

Pilgrim Foods Division of Old Dutch Mustard Co., Inc. in Greenville, New Hampshire was inspected by the Food and Drug Administration (FDA) on July 12 for foodborne biological hazards and received one citation, according to data posted on the FDA’s official website.

The FDA website shows that the company was cited for the following problem: ‘You did not exclude pests from your food plant to protect against contamination of food.’

The FDA routinely inspects facilities across the nation to determine if the workplaces and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly for businesses to consistently make smarter business decisions for the future.

The FDA is a government agency that is primarily responsible for monitoring the manufacturing and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality, according to its website.



Related

Ross Berry, New Hampshire State Representative for Hillsborough 44th District

Ross Berry comments on economic strain and GOP prospects in New England

Ross Berry addressed economic concerns and political trends in his tweets from May 12 and May 14, 2026.

Nashua

Nashua offers free CityBus rides for Cone With a Cop event on May 16

Nashua residents can ride CityBus for free on May 16 when attending PAL’s Cone With a Cop at Hayward’s Ice Cream. Children under age 13 get a complimentary scoop as part of this community outreach involving local police, fire rescue, and AMR.

Dr. Mehmet Oz CMS Administrator

Manchester Medicaid payments for Procedures / Professional Services reach $9,587,076 in 2024

Manchester saw a 179.4% rise in Medicaid spending for the Procedures / Professional Services category in 2024, signaling major changes in usage and reimbursement trends.